Arrowhead Pharmaceuticals Inc (ARWR) — Net Asset Quality Index
Arrowhead Pharmaceuticals Inc (ARWR) has a Net Asset Quality Index of 36.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.39 Billion minus total liabilities of $881.88 Million yields net assets of $503.42 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Arrowhead Pharmaceuticals Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Arrowhead Pharmaceuticals Inc Net Asset Quality Index Over Time (1997–2025)
This chart shows how Arrowhead Pharmaceuticals Inc's Net Asset Quality Index has evolved across 29 annual periods from 1997 to 2025. As of September 2025, the index stands at 36.3%, representing net assets of $503.42 Million against total assets of $1.39 Billion USD. See Arrowhead Pharmaceuticals Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Arrowhead Pharmaceuticals Inc (1997–2025)
The table below presents the year-by-year Net Asset Quality Index for Arrowhead Pharmaceuticals Inc from 1997 to 2025, covering 29 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ARWR market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.7% | $503.42 Million | $1.45 Billion | $947.02 Million | ▲ +17.9 pp |
| 2024 | 16.8% | $191.06 Million | $1.14 Billion | $948.74 Million | ▼ -20.7 pp |
| 2023 | 37.5% | $287.16 Million | $765.55 Million | $478.39 Million | ▼ -22.9 pp |
| 2022 | 60.5% | $418.34 Million | $691.94 Million | $273.60 Million | ▲ +2.9 pp |
| 2021 | 57.6% | $408.82 Million | $710.15 Million | $301.33 Million | ▼ -30.8 pp |
| 2020 | 88.4% | $461.78 Million | $522.50 Million | $60.72 Million | ▲ +18.6 pp |
| 2019 | 69.8% | $244.04 Million | $349.85 Million | $105.81 Million | ▼ -15.6 pp |
| 2018 | 85.3% | $95.24 Million | $111.61 Million | $16.37 Million | ▲ +7.6 pp |
| 2017 | 77.7% | $80.87 Million | $104.02 Million | $23.16 Million | ▲ +3.6 pp |
| 2016 | 74.1% | $95.02 Million | $128.18 Million | $33.15 Million | ▼ -8.7 pp |
| 2015 | 82.9% | $109.62 Million | $132.27 Million | $22.65 Million | ▼ -7.9 pp |
| 2014 | 90.8% | $165.99 Million | $182.82 Million | $16.83 Million | ▲ +21.9 pp |
| 2013 | 68.9% | $25.73 Million | $37.33 Million | $11.59 Million | ▲ +15.6 pp |
| 2012 | 53.3% | $8.81 Million | $16.53 Million | $7.72 Million | ▼ -25.8 pp |
| 2011 | 79.1% | $12.56 Million | $15.89 Million | $3.32 Million | ▲ +13.7 pp |
| 2010 | 65.4% | $8.08 Million | $12.35 Million | $4.28 Million | ▲ +2.3 pp |
| 2009 | 63.1% | $4.86 Million | $7.70 Million | $2.84 Million | ▼ -8.2 pp |
| 2008 | 71.3% | $12.30 Million | $17.26 Million | $4.95 Million | ▼ -17.3 pp |
| 2007 | 88.6% | $26.46 Million | $29.85 Million | $3.40 Million | ▼ -2.9 pp |
| 2006 | 91.5% | $31.61 Million | $34.53 Million | $2.92 Million | ▼ -4.9 pp |
| 2005 | 96.5% | $28.02 Million | $29.04 Million | $1.02 Million | ▲ +2.3 pp |
| 2004 | 94.2% | $11.23 Million | $11.92 Million | $689.70K | ▲ +0.6 pp |
| 2003 | 93.7% | $1.42 Million | $1.52 Million | $96.18K | ▲ +2533.3 pp |
| 2002 | -2439.7% | $-1.55 Million | $63.56K | $1.61 Million | ▲ +377.5 pp |
| 2001 | -2817.1% | $-1.30 Million | $46.30K | $1.35 Million | ▼ -1083.9 pp |
| 2000 | -1733.2% | $-1.13 Million | $65.15K | $1.19 Million | ▼ -522.8 pp |
| 1999 | -1210.4% | $-996.10K | $82.29K | $1.08 Million | ▲ +1888.9 pp |
| 1998 | -3099.4% | $-2.63 Million | $84.78K | $2.71 Million | ▼ -706.9 pp |
| 1997 | -2392.5% | $-2.58 Million | $107.68K | $2.68 Million | — |